Generics Bulletin
HBW Insight
In Vivo
Medtech Insight
Pink Sheet
Scrip
Close
Search
Search
Generics Bulletin
HBW Insight
In Vivo
Medtech Insight
Pink Sheet
Scrip
Should Obese Patients Be Included In Every Drug Development Program?
Jan 18 2023
•
By
Brenda Sandburg
Experts consider how obese patients should be included in drug development studies • Source: Shutterstock
More from Clinical Trials
More from R&D